Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotterdam Antiplatelet Therapy in Vascular Patients Study
2016-000686-23Phase 4Terminated
- Sponsor
- Erasmus MC
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel in Myocardial injury, acute coronary syndrome (ACS) and cardiac morbidity, sponsored by Erasmus MC. Primary endpoint: Efficacy outcomes. Started Jun 2016; status: terminated.
02
Drugs
clopidogrel
03
Conditions
Myocardial injuryacute coronary syndrome (ACS)cardiac morbidity
Beyond the preview
Go deeper on 2016-000686-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000686-23.